Literature DB >> 15082598

Developments in liver transplantation.

J Neuberger1.   

Abstract

Mesh:

Year:  2004        PMID: 15082598      PMCID: PMC1774054          DOI: 10.1136/gut.2003.024927

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  82 in total

1.  Pros and cons of using interleukin-2 receptor antibodies in liver transplant recipients.

Authors:  Ryutaro Hirose
Journal:  Liver Transpl       Date:  2002-02       Impact factor: 5.799

2.  Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma.

Authors:  Ziad Hassoun; Gregory J Gores; Charles B Rosen
Journal:  Surg Oncol Clin N Am       Date:  2002-10       Impact factor: 3.495

Review 3.  Hepatocellular carcinoma: present status and future prospects.

Authors:  Josep M Llovet; Michel Beaugrand
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

4.  A highly efficient, stable, and rapid approach for ex vivo human liver gene therapy via a FLAP lentiviral vector.

Authors:  Carlo Giannini; Serban Morosan; J Guilherme Tralhao; Jacques Emmanuel Guidotti; Serena Battaglia; Karine Mollier; Laurent Hannoun; Dina Kremsdorf; Helene Gilgenkrantz; Pierre Charneau
Journal:  Hepatology       Date:  2003-07       Impact factor: 17.425

5.  Factors influencing the adaptation of the Spanish Model of organ donation.

Authors:  Rafael Matesanz
Journal:  Transpl Int       Date:  2003-07-03       Impact factor: 3.782

6.  Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients.

Authors:  Mohsen Shabahang; Dido Franceschi; Noriyo Yamashiki; Raj Reddy; Peter A Pappas; Kuky Aviles; Sonia Flores; Andrea Chaparro; Joseph U Levi; Danny Sleeman; Andreas G Tzakis; Tomoaki Kato; David M Levi; Alan S Livingstone
Journal:  Ann Surg Oncol       Date:  2002-11       Impact factor: 5.344

Review 7.  Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature.

Authors:  Z Ben-Ari; E Mor; R Tur-Kaspa
Journal:  J Intern Med       Date:  2003-05       Impact factor: 8.989

8.  Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

Authors:  Didier Samuel; Thierry Bizollon; Cyrille Feray; Bruno Roche; Si Nafa Si Ahmed; Catherine Lemonnier; Marielle Cohard; Michel Reynes; Michelle Chevallier; Christian Ducerf; Jacques Baulieux; Michael Geffner; Janice K Albrecht; Henri Bismuth; Christian Trepo
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

Review 9.  FTY720: A new kid on the block for transplant immunosuppression.

Authors:  Fazil Tuncay Aki; Barry D Kahan
Journal:  Expert Opin Biol Ther       Date:  2003-07       Impact factor: 4.388

10.  Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications.

Authors:  Peter Abt; Michael Crawford; Niraj Desai; James Markmann; Kim Olthoff; Abraham Shaked
Journal:  Transplantation       Date:  2003-05-27       Impact factor: 4.939

View more
  5 in total

Review 1.  Mortality from cirrhosis: lack of progress over the last 35 years.

Authors:  C Gluud
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

2.  [Liver transplantation: deciding between need and donor allocation].

Authors:  C P Strassburg; T Becker; J Klempnauer; M P Manns
Journal:  Internist (Berl)       Date:  2004-11       Impact factor: 0.743

Review 3.  Molecular basis and current treatment for alcoholic liver disease.

Authors:  Alejandra Miranda-Mendez; Alejandro Lugo-Baruqui; Juan Armendariz-Borunda
Journal:  Int J Environ Res Public Health       Date:  2010-04-27       Impact factor: 3.390

4.  The Effects of Short-Term Immunosuppressive Therapy on Redox Parameters in the Livers of Pregnant Wistar Rats.

Authors:  Dagmara Szypulska-Koziarska; Aleksandra Wilk; Joanna Kabat-Koperska; Agnieszka Kolasa-Wołosiuk; Jolanta Wolska; Barbara Wiszniewska
Journal:  Int J Environ Res Public Health       Date:  2019-04-16       Impact factor: 3.390

Review 5.  Inventing Engineered Organoids for end-stage liver failure patients.

Authors:  Radiana D Antarianto; Amer Mahmood; Angela Giselvania; Ayu Aa Prima Asri Dewi; Jatmiko Gustinanda; Jeanne Adiwinata Pawitan
Journal:  J Mol Histol       Date:  2022-07-27       Impact factor: 3.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.